Log in
Enquire now
‌

AxNano, Llc SBIR Phase II Award, September 2020

A SBIR Phase II contract was awarded to AxNano, Llc in September, 2020 for $439,723.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

OverviewStructured DataIssuesContributors

Contents

sbir.gov/node/1918015
Is a
SBIR/STTR Awards
SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient
AxNano, Llc
AxNano, Llc
0
Government Agency
0
Government Branch
National Institutes of Health
National Institutes of Health
0
Award Type
SBIR0
Contract Number (US Government)
4R44ES031461-020
Award Phase
Phase II0
Award Amount (USD)
439,7230
Date Awarded
September 9, 2020
0
End Date
August 31, 2022
0
Abstract

Project Summary/Abstract AxNano, LLC SBIR Fasttrack 2019 The EPA estimates that one out of every four Americans lives within three miles of a hazardous waste site. To meet the growing need for remediating these contaminated sites, the US remediation market has been increasing steadily since 2009, averaging 2-3% increases per year. The global environmental remediation technology market is forecasted to expand to $80.5 billion in 2019. Remediation of contaminated sites can cost upwards of millions of dollars and can last for decades, especially in challenging geological settings such as low permeability (low-k) zones (e.g., clay and bedrock). Sites where contaminants are concentrated in low permeability zones are a particular industry headache as these areas can serve as sub-surface “source zones” providing slow release of contaminants into transmissive zones for decades of longer. Traditional, liquid-phase remediation injections that are successfully used in more permeable areas, when applied to low-k zones often result in only partial clean-up followed by chronic site management. Costly re-applications to address rebounding (increases in contaminant concentration following remediation) and tailings (persistent non-zero contaminant levels) are one of the biggest pain-points for environmental engineers. These rebounding and tailings lead to increase liability, increased remediation cost, and long drawn-out remediation schemes. AxNano, in collaboration with North Carolina Aandamp;T, has specially formulated their patented controlled release technology to address these persistent low-k zones. RemRx® CRI, controlled release injectant, can be emplaced into low k zones by hydraulic fracturing and provide sustained levels of ISCO reagents directly into the trapped contaminated area with one/few applications to address these issues of rebounding and tailings. AxNano has established prototypes and preliminary studies to support a Fasttrack SBIR program. Phase I of the program will support the development RemRx® CRI, through bench-scale testing of prototypes in low- k zone 2-D flow chambers and radius of influence estimation by computational modeling. Phase II aims to pilot- scale demonstrate manufacturing the Phase I-validated MVP and field test at two sites in the Piedmont Region. Field demonstrations will include comparison to straight oxidant performance. Data from pilot-scale demonstration and computational modeling will be used to design full-scale deployments. AxNano will design a full scale manufacturing process to support transition of the RemRxTM CRI technology to future large scale deployment. This technology development program leverages a unique intellectual property position to develop this new RemRxTM family of products. The remediation and broader water/wastewater markets are complex, making market uptake of new remediation technologies difficult. However, controlled release ISCO agents are of strong interest. The AxNano Team is committed to achieving the successful commercialization of this high-impact technology.Project Narrative Hazardous chemicals released into the environment can get trapped in low permeability zones in the ground, like clay or bedrock, contaminating drinking water sources or affecting indoor air quality for decades or longer. Remediation of these low permeability zones is difficult using current methods and amendments, thus common approaches are focused on treating fluxes from the areas instead of targeting the sources themselves. To meet this need, AxNano LLC, is developing RemRxTM CRI, an injectable controlled-release in situ chemical oxidation material that can be placed into low permeability zones via hydraulic fracturing, that will lower total project cost, shorten the overall clean-up cycle, and decrease chronic human exposure resulting from hazardous chemical releases.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like AxNano, Llc SBIR Phase II Award, September 2020

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.